These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 9460552

  • 1. Streptavidin in antibody pretargeting. Comparison of a recombinant streptavidin with two streptavidin mutant proteins and two commercially available streptavidin proteins.
    Wilbur DS, Stayton PS, To R, Buhler KR, Klumb LA, Hamlin DK, Stray JE, Vessella RL.
    Bioconjug Chem; 1998; 9(1):100-7. PubMed ID: 9460552
    [Abstract] [Full Text] [Related]

  • 2. Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers.
    Wilbur DS, Pathare PM, Hamlin DK, Buhler KR, Vessella RL.
    Bioconjug Chem; 1998; 9(6):813-25. PubMed ID: 9815176
    [Abstract] [Full Text] [Related]

  • 3. Biotin reagents for antibody pretargeting. 2. Synthesis and in vitro evaluation of biotin dimers and trimers for cross-linking of streptavidin.
    Wilbur DS, Pathare PM, Hamlin DK, Weerawarna SA.
    Bioconjug Chem; 1997; 8(6):819-32. PubMed ID: 9404654
    [Abstract] [Full Text] [Related]

  • 4. Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.
    Wilbur DS, Park SI, Chyan MK, Wan F, Hamlin DK, Shenoi J, Lin Y, Wilbur SM, Buchegger F, Pantelias A, Pagel JM, Press OW.
    Bioconjug Chem; 2010 Jul 21; 21(7):1225-38. PubMed ID: 20597486
    [Abstract] [Full Text] [Related]

  • 5. Streptavidin in antibody pretargeting. 3. Comparison of biotin binding and tissue localization of 1,2-cyclohexanedione and succinic anhydride modified recombinant streptavidin.
    Wilbur DS, Hamlin DK, Meyer DL, Mallett RW, Quinn J, Vessella RL, Press OW.
    Bioconjug Chem; 2002 Jul 21; 13(3):611-20. PubMed ID: 12009953
    [Abstract] [Full Text] [Related]

  • 6. Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma.
    Park SI, Shenoi J, Frayo SM, Hamlin DK, Lin Y, Wilbur DS, Stayton PS, Orgun N, Hylarides M, Buchegger F, Kenoyer AL, Axtman A, Gopal AK, Green DJ, Pagel JM, Press OW.
    Clin Cancer Res; 2011 Dec 01; 17(23):7373-82. PubMed ID: 21976541
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antibody-dependent signal amplification in tumor xenografts after pretreatment with biotinylated monoclonal antibody and avidin or streptavidin.
    Kassis AI, Jones PL, Matalka KZ, Adelstein SJ.
    J Nucl Med; 1996 Feb 01; 37(2):343-52. PubMed ID: 8667075
    [Abstract] [Full Text] [Related]

  • 12. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS, Chyan MK, Hamlin DK, Vessella RL, Wedge TJ, Hawthorne MF.
    Bioconjug Chem; 2007 Feb 01; 18(4):1226-40. PubMed ID: 17583925
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biotin reagents for antibody pretargeting. 4. Selection of biotin conjugates for in vivo application based on their dissociation rate from avidin and streptavidin.
    Wilbur DS, Chyan MK, Pathare PM, Hamlin DK, Frownfelter MB, Kegley BB.
    Bioconjug Chem; 2000 Feb 01; 11(4):569-83. PubMed ID: 10898580
    [Abstract] [Full Text] [Related]

  • 15. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    Bioconjug Chem; 1997 Feb 01; 8(5):724-9. PubMed ID: 9327137
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preclinical evaluation of a humanized NR-LU-10 antibody-streptavidin fusion protein for pretargeted cancer therapy.
    Goshorn S, Sanderson J, Axworthy D, Lin Y, Hylarides M, Schultz J.
    Cancer Biother Radiopharm; 2001 Apr 01; 16(2):109-23. PubMed ID: 11385958
    [Abstract] [Full Text] [Related]

  • 18. Radioiodinated iodobenzoyl conjugates of a monoclonal antibody Fab fragment. In vivo comparisons with chloramine-T-labeled Fab.
    Wilbur DS, Hadley SW, Grant LM, Hylarides MD.
    Bioconjug Chem; 1991 Apr 01; 2(2):111-6. PubMed ID: 1868113
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A tetravalent single-chain antibody-streptavidin fusion protein for pretargeted lymphoma therapy.
    Schultz J, Lin Y, Sanderson J, Zuo Y, Stone D, Mallett R, Wilbert S, Axworthy D.
    Cancer Res; 2000 Dec 01; 60(23):6663-9. PubMed ID: 11118050
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.